Contrast Induced Nephropathy and Chronic Kidney Disease (CIN CKD) as a consequence of utilising non ionic Iso-Osmolar Contrast Media (IOCM) versus Low-Osmolar Contrast Media (LOCM) following lower extremity endovascular revascularisation (EvR): A 5 years parallel group observational study. SITE: 9th International Symposium on Endovascular Therapeutics

SHERIF SULTAN

Contrast Induced Nephropathy and Chronic Kidney Disease (CIN CKD) as a consequence of utilising non ionic Iso-Osmolar Contrast Media (IOCM) versus Low-Osmolar Contrast Media (LOCM) following lower extremity endovascular revascularisation (EvR): A 5 years parallel group observational study. SITE: 9th International Symposium on Endovascular Therapeutics

SHERIF SULTAN

Surgery

Research output: Other contribution (Published) › Other contribution

Original language	English (Ireland)
Media of output	Conference Poster
Place of Publication	Barcelona, Spain
Publication status	Published - 1 May 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

SULTAN, SHERIF. (2011, May 1). Contrast Induced Nephropathy and Chronic Kidney Disease (CIN CKD) as a consequence of utilising non ionic Iso-Osmolar Contrast Media (IOCM) versus Low-Osmolar Contrast Media (LOCM) following lower extremity endovascular revascularisation (EvR): A 5 years parallel group observational study. SITE: 9th International Symposium on Endovascular Therapeutics.

SULTAN, SHERIF. / Contrast Induced Nephropathy and Chronic Kidney Disease (CIN CKD) as a consequence of utilising non ionic Iso-Osmolar Contrast Media (IOCM) versus Low-Osmolar Contrast Media (LOCM) following lower extremity endovascular revascularisation (EvR): A 5 years parallel group observational study. SITE: 9th International Symposium on Endovascular Therapeutics. 2011. Barcelona, Spain.

@misc{5764fde6f6df4328a745413c64eb5ace,

title = "Contrast Induced Nephropathy and Chronic Kidney Disease (CIN CKD) as a consequence of utilising non ionic Iso-Osmolar Contrast Media (IOCM) versus Low-Osmolar Contrast Media (LOCM) following lower extremity endovascular revascularisation (EvR): A 5 years parallel group observational study. SITE: 9th International Symposium on Endovascular Therapeutics",

author = "SHERIF SULTAN",

year = "2011",

month = may,

day = "1",

language = "English (Ireland)",

type = "Other",

}

SULTAN, SHERIF 2011, Contrast Induced Nephropathy and Chronic Kidney Disease (CIN CKD) as a consequence of utilising non ionic Iso-Osmolar Contrast Media (IOCM) versus Low-Osmolar Contrast Media (LOCM) following lower extremity endovascular revascularisation (EvR): A 5 years parallel group observational study. SITE: 9th International Symposium on Endovascular Therapeutics. Barcelona, Spain.

Contrast Induced Nephropathy and Chronic Kidney Disease (CIN CKD) as a consequence of utilising non ionic Iso-Osmolar Contrast Media (IOCM) versus Low-Osmolar Contrast Media (LOCM) following lower extremity endovascular revascularisation (EvR): A 5 years parallel group observational study. SITE: 9th International Symposium on Endovascular Therapeutics. / SULTAN, SHERIF.
Barcelona, Spain. 2011.

Research output: Other contribution (Published) › Other contribution

TY - GEN

T1 - Contrast Induced Nephropathy and Chronic Kidney Disease (CIN CKD) as a consequence of utilising non ionic Iso-Osmolar Contrast Media (IOCM) versus Low-Osmolar Contrast Media (LOCM) following lower extremity endovascular revascularisation (EvR): A 5 years parallel group observational study. SITE: 9th International Symposium on Endovascular Therapeutics

AU - SULTAN, SHERIF

PY - 2011/5/1

Y1 - 2011/5/1

M3 - Other contribution

CY - Barcelona, Spain

ER -

SULTAN SHERIF. Contrast Induced Nephropathy and Chronic Kidney Disease (CIN CKD) as a consequence of utilising non ionic Iso-Osmolar Contrast Media (IOCM) versus Low-Osmolar Contrast Media (LOCM) following lower extremity endovascular revascularisation (EvR): A 5 years parallel group observational study. SITE: 9th International Symposium on Endovascular Therapeutics. 2011.